IGM Biosciences Appoints Senior Vice President, Quality

Mar 21, 2023

Elaine Sapinoso Named Senior Vice President of Quality at IGM Biosciences

IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, recently appointed Elaine Sapinoso as the Senior Vice President of Quality.

Sapinoso has a decorated history serving in senior Quality leadership roles at global drug development and manufacturing organizations supporting biologics drug substance and drug product operations, and provided leadership across Quality functions including Quality Assurance, Quality Control, and Validation. She joins IGM Biosciences from Abzena where she was the the Senior Vice President of Global Quality. Prior to that, she was Vice President of QUality and Regulatory as Aji BioPharma. Throughout her 26 years in Quality positions, she has led manufacturing facilities through successful regulatory site inspections resulting in eleven commercial facility and product approvals.

Sapinoso earned a B.S. in Biology from De La Salle University, and an M.B.A. from the University of California, Los Angeles with a specialization in Corporate Governance.

View her full bio from IGM Biosciences here.

Executive Search Partnership: IGM Biosciences


ON Partners partner Suzanne Zebedee Ph.D. is proud to have partnered with IGM Biosciences on the Senior Vice President, Quality executive search placement. Review more of our executive search placements in our Executive Talent Report.

IGM Biosciences is a clinical-stage biotechnology company committed to developing and delivering a new class of medicines to treat patients with cancer, infectious diseases and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only 2 binding sites. The Company also has an exclusive worldwide collaboration agreement with Sanofi to create, develop, manufacture, and commercialize IgM antibody agonists against oncology and immunology and inflammation targets. For more information, please visit www.igmbio.com.

To learn more about partnering with our executive search firm, meet our executive search consultants.

About ON Partners

Since 2006, ON Partners is the only pure-play executive search firm building diverse C-level and board leadership teams. We rebuilt the institution of executive search for the way you work. Our approach includes present partners who engage with their clients from the first brief to the final decision, individually crafted solutions that are unique to each client, and an easier experience all around. Named by Forbes as one of America’s Best Executive Recruiting Firms and to the Inc. 500/5000 Lists nine times, ON Partners is consistently ranked among the top 20 retained executive search firms in the U.S.

Untraditional by Choice. Original by Design. Since 2006.

Start your journey with us today.

If you want to create a new path – ON Partners knows how to help you get there.